Advertisement
ALGN vs STXS
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGN is a Hold and STXS is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ALGN’s FA Score shows that 0 FA rating(s) are green whileSTXS’s FA Score has 0 green FA rating(s).
- ALGN’s FA Score: 0 green, 5 red.
- STXS’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ALGN’s TA Score shows that 5 TA indicator(s) are bullish while STXS’s TA Score has 4 bullish TA indicator(s).
- ALGN’s TA Score: 5 bullish, 4 bearish.
- STXS’s TA Score: 4 bullish, 5 bearish.
Price Growth
ALGN (@Pharmaceuticals: Other) experienced а -5.62% price change this week, while STXS (@Pharmaceuticals: Other) price change was -7.82% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.03%. For the same industry, the average monthly price growth was -0.29%, and the average quarterly price growth was +8.18%.
Reported Earning Dates
ALGN is expected to report earnings on Feb 04, 2026.
STXS is expected to report earnings on Feb 27, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (-2.03% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| ALGN | STXS | ALGN / STXS | |
| Capitalization | 9.6B | 209M | 4,591% |
| EBITDA | 793M | -22.41M | -3,538% |
| Gain YTD | -35.864 | -1.754 | 2,044% |
| P/E Ratio | 25.92 | N/A | - |
| Revenue | 3.97B | 31.8M | 12,469% |
| Total Cash | 901M | 6.97M | 12,932% |
| Total Debt | 123M | 5.73M | 2,148% |
ALGN | STXS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 71 | 60 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 75 Overvalued | 99 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 63 | 100 | |
PRICE GROWTH RATING 1..100 | 63 | 63 | |
P/E GROWTH RATING 1..100 | 81 | 48 | |
SEASONALITY SCORE 1..100 | n/a | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ALGN's Valuation (75) in the Medical Specialties industry is in the same range as STXS (99). This means that ALGN’s stock grew similarly to STXS’s over the last 12 months.
ALGN's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as STXS (100). This means that ALGN’s stock grew similarly to STXS’s over the last 12 months.
ALGN's SMR Rating (63) in the Medical Specialties industry is somewhat better than the same rating for STXS (100). This means that ALGN’s stock grew somewhat faster than STXS’s over the last 12 months.
ALGN's Price Growth Rating (63) in the Medical Specialties industry is in the same range as STXS (63). This means that ALGN’s stock grew similarly to STXS’s over the last 12 months.
STXS's P/E Growth Rating (48) in the Medical Specialties industry is somewhat better than the same rating for ALGN (81). This means that STXS’s stock grew somewhat faster than ALGN’s over the last 12 months.
| ALGN | STXS | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 62% |
| Stochastic ODDS (%) | 1 day ago 75% | 1 day ago 80% |
| Momentum ODDS (%) | 1 day ago 73% | 1 day ago 85% |
| MACD ODDS (%) | 1 day ago 71% | N/A |
| TrendWeek ODDS (%) | 1 day ago 72% | 1 day ago 83% |
| TrendMonth ODDS (%) | 1 day ago 76% | 1 day ago 81% |
| Advances ODDS (%) | 10 days ago 73% | 10 days ago 77% |
| Declines ODDS (%) | 3 days ago 73% | 4 days ago 80% |
| BollingerBands ODDS (%) | 1 day ago 66% | 1 day ago 89% |
| Aroon ODDS (%) | 1 day ago 71% | 1 day ago 86% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CHAT | 59.21 | 0.17 | +0.29% |
| Roundhill Generative AI & Technology ETF | |||
| NJUL | 70.93 | 0.17 | +0.24% |
| Innovator Nasdaq-100 Power Bfr ETF Jul | |||
| QVOY | 27.80 | 0.02 | +0.07% |
| Q3 All-Season Active Rotation ETF | |||
| AGRW | 30.10 | N/A | N/A |
| Allspring LT Large Growth ETF | |||
| HTAX | 24.50 | -0.07 | -0.27% |
| Macquarie National High-Yield Municipal Bond ETF | |||
ALGN and
Correlation & Price change
A.I.dvisor indicates that over the last year, ALGN has been loosely correlated with BAX. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGN jumps, then BAX could also see price increases.
| Ticker / NAME | Correlation To ALGN | 1D Price Change % | ||
|---|---|---|---|---|
| ALGN | 100% | +1.10% | ||
| BAX - ALGN | 65% Loosely correlated | -2.53% | ||
| NVST - ALGN | 57% Loosely correlated | -0.94% | ||
| XRAY - ALGN | 53% Loosely correlated | -1.61% | ||
| LUNG - ALGN | 52% Loosely correlated | -1.07% | ||
| SAUHY - ALGN | 49% Loosely correlated | N/A | ||
More | ||||
STXS and
Correlation & Price change
A.I.dvisor indicates that over the last year, STXS has been loosely correlated with SMTI. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if STXS jumps, then SMTI could also see price increases.
| Ticker / NAME | Correlation To STXS | 1D Price Change % | ||
|---|---|---|---|---|
| STXS | 100% | -2.18% | ||
| SMTI - STXS | 39% Loosely correlated | -8.06% | ||
| TWST - STXS | 36% Loosely correlated | -2.12% | ||
| CERS - STXS | 35% Loosely correlated | +1.34% | ||
| ALGN - STXS | 34% Loosely correlated | +1.10% | ||
| NVST - STXS | 33% Loosely correlated | -0.94% | ||
More | ||||